Clinical standards for patient blood management and perioperative hemostasis and coagulation management. Position paper of the Italian society of anesthesia, analgesia, resuscitation and intensive care (Siaarti)

Minerva Anestesiologica

Volumn 85, Issue 6, 2019, Pages 635-664

  Cinnella, Gilda ^a   Pavesi, Marco ^b   de Gasperi, Andrea ^c   Ranucci, Marco ^b   Mirabella, Lucia ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b IRCCS   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Blood component transfusion; Hemostasis; Perioperative care

Indexed keywords

ANTICOAGULANT AGENT; HEMOGLOBIN; IRON; LOW MOLECULAR WEIGHT HEPARIN;

ANEMIA; ANTICOAGULANT THERAPY; BLOOD; BLOOD CLOTTING DISORDER; BLOOD CONSERVATION; BLOOD TRANSFUSION REACTION; HEMOSTASIS; HUMAN; IMMUNOMODULATION; INTENSIVE CARE; MEDICAL SOCIETY; ORGAN PERFUSION; OXYGENATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; REVIEW; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION; BLOOD TRANSFUSION; HEMOSTATIC TECHNIQUE; PRACTICE GUIDELINE;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HEMOSTATIC TECHNIQUES; HUMANS; PERIOPERATIVE CARE;

EID: 85066935122     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: 10.23736/S0375-9393.19.12151-7     Document Type: Review

References (150)

1. National Blood Authotity. Patient Blood Management Guidelines: Module 2 Perioperative. 9 March 2012 [Internet]. Available from https://www.blood.gov.au/system/files/documents/pbm-module-2 [cited 2019, Apr 24].
2. Vaglio S, Gentili S, Marano G, Pupella S, Rafanelli D, Biancofiore G, et al. The Italian Regulatory Guidelines for the implementation of Patient Blood Management. Blood Trans-fus 2017;15:325–8.
3. NICE guideline NG24. Blood Transfusion - Methods, evidence and recommendations. National Institute for Health and Care Excellence. Nov 2015.
4. Meybohm P, Herrmann E, Steinbicker AU, Wittmann M, Gruenewald M, Fischer D, et al.; PBM-study Collaborators. Patient Blood Management is associated with a substantial reduction of red blood cell utilization and safe for patient’s outcome. A prospective, multicenter cohort study with a non-inferiority design. Ann Surg 2016;264:203–11.
5. De Hert S, Imberger G, Carlisle J, Diemunsch P, Fritsch G, Moppett I, et al.; Task Force on Preoperative Evaluation of the Adult Noncardiac Surgery Patient of the European Society of Anaesthesiology. Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2011;28:684–722.
6. Boehm O, Baumgarten G, Hoeft A. Preoperative patient assessment: identifying patients at high risk. Best Pract Res Clin Anaesthesiol 2016;30:131–43.
7. Circular of Information for the Use of Human Blood and Blood Components. Bethesda, MD: American Association of Blood Banks; 2000.
8. Gonzalez-Porras JR, Colado E, Conde MP, Lopez T, Nieto MJ, Corral M. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009;19:35–42.
9. Pavesi M, Inghilleri G, Albano G, Ricci C, Gaeta M, Randelli F. A predictive model to reduce allogenic transfusions in primary total hip arthroplasty. Transfus Apheresis Sci 2011;45:265–8.
10. Jo KI, Shin JW. Can maximum surgical blood order schedule be used as a predictor of successful completion of bloodless surgery? Ann Lab Med 2013;33:116–20.
11. Meybohm P, Fischer DP, Geisen C, Müller MM, Weber CF, Herrmann E, et al.; German PBM Study Core Group. Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients—the study design for a multi-centre prospective epidemiologic non-inferiority trial. BMC Health Serv Res 2014;14:576.
12. Lasocki S, Krauspe R, von Heymann C, Mezzacasa A, Chainey S, Spahn DR. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol 2015;32:160–7.
13. van Iperen CE, van de Wiel A, Marx JJ. Acute event-related anaemia. Br J Haematol 2001;115:739–43.
14. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998;85:41–5.
15. von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol 2015;12:659–69.
16. Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zam-browski JJ, Mebazaa A, et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart 2014;100:1414–20.
17. Kozek-Langenecker SA, Ahmed AB, Afshari A, Al-baladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017;34:332–95.
18. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011;106:13–22.
19. Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 2015;102:1314–24.
20. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011;378:1396–407.
21. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017;57:1347–58.
22. Hung M, Ortmann E, Besser M, Martin-Cabrera P, Richards T, Ghosh M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2015;101:107–12.
23. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007;297:2481–8.
24. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, Shander A, Richards T, Pavía J, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth 2015;115:15–24.
25. WHO Scientific Group on Nutritional Anaemias & World Health Organization 1968. Nutritional anaemias: report of a WHO scientific group [meeting held in Geneva from 13 to 17 March 1967].
26. WHO. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.
27. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007;47:1468–80.
28. Muñoz M, Gómez-Ramírez S, Campos A, Ruiz J, Li-umbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus 2015;13:370–9.
29. Muñoz M, Laso-Morales MJ, Gómez-Ramírez S, Cadel-las M, Núñez-Matas MJ, García-Erce JA. Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery. Anaesthesia 2017;72:826–34.
30. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011–23.
31. Partridge J, Harari D, Gossage J, Dhesi J. Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. J R Soc Med 2013;106:269–77.
32. Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr 2008;8:1–8.
33. Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, et al.; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 2014;113:416–23.
34. Blaudszun G, Munting KE, Butchart A, Gerrard C, Klein AA. The association between borderline pre-operative anaemia in women and outcomes after cardiac surgery: a cohort study. Anaesthesia 2018;73:572–8.
35. Grant MC, Whitman GJ, Savage WJ, Ness PM, Frank SM. Clinical predictors of postoperative hemoglobin drift. Transfusion 2014;54:1460–8.
36. Smilowitz NR, Oberweis BS, Nukala S, Rosenberg A, Zhao S, Xu J, et al. Association Between Anemia, Bleeding, and Transfusion with Long-term Mortality Following Noncardiac Surgery. Am J Med 2016;129:315–23.e2.
37. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012;147:49–55.
38. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006;1(Suppl 1):S4–8.
39. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santul-lano CA, De Robertis E, Filipescu DC, et al.; Guidelines from the European Society of Anaesthesiology. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270–382.
40. Muñoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017;72:233–47.
41. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009;73–9.
42. Pierce A, Nester T; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol 2011;136:7–12.
43. McEvoy MT, Shander A. Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies. Am J Crit Care 2013;22(Suppl):eS1–13.
44. Ng O, Keeler BD, Mishra A, Simpson A, Neal K, Brookes MJ, et al. Iron therapy for pre-operative anaemia. Cochrane Database Syst Rev 2015;12:CD011588.
45. Auerbach M, Goodnough LT, Shander A. Iron: the new advances in therapy. Best Pract Res Clin Anaesthesiol 2013;27:131–40.
46. Keating GM. Ferric carboxymaltose: a review of its use in iron deficiency. Drugs 2015;75:101–27.
47. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008;100:599–604.
48. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015;122:241–75.
49. Klein AA, Arnold P, Bingham RM, Brohi K, Clark R, Col-lis R, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016;71:829–42.
50. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009;12:444–54.
51. Blanc B, Finch CA, Hallberg L, Herbert V, Lawkowicz W, Layrisse M. Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech Rep Ser 1968;1–40.
52. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK et al. Clinical Practice Guidelines From the AABB Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016;316:2025–35.
53. Muñoz M, Gómez-Ramírez S, Cuenca J, García-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014;54:289–99.
54. Kotzé A, Harris A, Baker C, Iqbal T, Lavies N, Richards T, et al. British Committee for standards in haematology guidelines on the identification and management of preoperative anaemia. Br J Haematol 2015;171:322–31.
55. Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci 2015;52:256–72.
56. Polin V, Coriat R, Perkins G, Dhooge M, Abitbol V, Leb-lanc S, et al. Iron deficiency: from diagnosis to treatment. Dig Liver Dis 2013;45:803–9.
57. Clevenger B, Richards T. Pre-operative anaemia. Anaesthesia 2015;70(Suppl 1):20–8, e6–8.
58. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 2017;4:e524–33.
59. Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev 2013;27:221–34.
60. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S. Preoperative haematological assessment in patients scheduled for major surgery. Anaesthesia 2016;71(Suppl 1):19–28.
61. De Hert S, Staender S, Fritsch G, Hinkelbein J Afshari A, Bettelli G, et al. ESA 2018 Pre-operative evaluation of adults undergoing elective noncardiac surgery. Eur J Anaesthesiol 2018;35:407–65.
62. Boer C, Meesters MI, Milojevic M, Benedetto U, Bol-liger D, von Heymann C, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiotho-racic Anaesthesiology (EACTA). J Cardiothorac Vasc Anesth 2018;53:79–111.
63. Raval AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, Diercks D, Piccini JP, et al.; American Heart Association Clinical Pharmacology Subcommittee of the Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Quality of Care and Outcomes Research. Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association. Circulation 2017;135:e604–33. [Erratum in:Circulation.2017Mar 7;135] [10] [: e647. Circulation.2017Jun 13;135] [24] [: e1144]
64. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al.; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213–60.
65. Rossini R, Tarantini G, Musumeci G, Masiero G, Barbato E, Calabrò P, et al.; Italian Society of Interventional Cardiology (SICI-GISE); Italian Society for the Study of Haemostasis and Thrombosis (SISET); Italian Society of Anesthesia and Intensive Care Medicine (SIAARTI); Italian Society of Surgery (SIC); Italian Society for Cardiac Surgery (SICCH); Italian Society of Vascular and Endovascular Surgery (SICVE); Italian Society of Urology (SIU); Italian Orthopaedic Society (SIOT); Italian Society of Thoracic Surgeons (SICT); Italian Federation of Scientific Societies of Digestive System Diseases (FISMAD); Italian Society of Digestive Endoscopy (SIED); Italian Association of Hospital Gastroenterology and Digestive Endoscopy (AIGO); Italian Association of Gastroenterology and Digestive Endoscopy (SIGE); Italian Society of Maxillofacial Surgery (SICMF); Italian Society of Reconstructive Plastic Surgery and Aesthetics (SICPRE); Italian Society of Gynecology and Obstetrics (SIGO); Italian Society of Neurosurgery (SINch); Italian Association of Hospital Pulmonologist (AIPO); Italian Society of Periodontology (SIdP); Italian Society of Ophthalmology (SOI); Italian Association of Hospital Otorhinolaryngologist (AOOI); Italian Association of Hospital Surgeons (ACOI); Association of Obstetricians Gynecologists Italian Hospital (AOGOI). A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. JACC Cardiovasc Interv 2018;11:417–34.
66. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015;17:1467–507.
67. Cappelleri G, Fanelli A. Use of direct oral anticoagulants with regional anesthesia in orthopedic patients. J Clin Anesth 2016;32:224–35.
68. Tripodi A, Ageno W, Ciaccio M, Legnani C, Lippi G, Manotti C, et al. Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL. Blood Transfus 2018;16:462–70.
69. Tripodi A, Chantarangkul V, Legnani C, Testa S, Tosetto A. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme. J Thromb Haemost 2018;16:565–70.
70. Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Del-lanoce C, et al.; START-Laboratory Register. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics. Thromb Res 2016;137:178–83.
71. Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015;373:511–20.
72. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015;373:2413–24.
73. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, et al.; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014;35:2383–431.
74. Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB, et al.; Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012;94:1761–81.
75. De Servi S, Morici N, Boschetti E, Rossini R, Martina P, Musumeci G, et al. Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: analysis of 314 patients. Vascul Pharmacol 2016;80:85–90.
76. Saia F, Belotti LM, Guastaroba P, Berardini A, Rossini R, Musumeci G, et al. Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? Circ Cardiovasc Qual Outcomes 2016;9:39–47.
77. Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Car-rié D, et al.; SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 2018;391:41–50.
78. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al.; American College of Cardiology; American Heart Association. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014;64:e77–137.
79. Rossini R, Musumeci G, Visconti LO, Bramucci E, Castiglioni B, De Servi S, et al.; Italian Society of Invasive Cardiology (SICI-GISE); Italian Association of Hospital Cardiologists (ANMCO); Italian Society for Cardiac Surgery (SICCH); Italian Society of Vascular and Endovascular Surgery (SICVE); Italian Association of Hospital Surgeons (ACOI); Italian Society of Surgery (SIC); Italian Society of Anaesthesia and Intensive Care Medicine (SIAARTI); Lom-bard Society of Surgery (SLC); Italian Society of Maxillofacial Surgery (SICMF); Italian Society of Reconstructive Plastic Surgery and Aesthetics (SICPRE); Italian Society of Thoracic Surgeons (SICT); Italian Society of Urology (SIU); Italian Society of Orthopaedics and Traumatology (SIOT); Italian Society of Periodontology (SIdP); Italian Federation of Scientific Societies of Digestive System Diseases Lombardia (FISMAD); Association of Obstetricians Gynaecologists Italian Hospital Lombardia (AOGOI); Society of Ophthalmology Lombardia (SOL). Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014;10:38–46.
80. Hansson EC, Jidéus L, Åberg B, Bjursten H, Dreifaldt M, Holmgren A, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016;37:189–97.
81. Rossini R, Angiolillo DJ, Musumeci G, Capodanno D, Lettino M, Trabattoni D, et al. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: results of the surgery after stenting registry. Catheter Cardiovasc Interv 2017;89:E13–25.
82. Rossini R, Musumeci G, Capodanno D, Lettieri C, Lim-bruno U, Tarantini G, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost 2015;113:272–82.
83. Morici N, Moja L, Rosato V, Sacco A, Mafrici A, Klug-mann S, et al. Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review. Intern Emerg Med 2014;9:225–35.
84. Childers CP, Maggard-Gibbons M, Ulloa JG, MacQueen IT, Miake-Lye IM, Shanman R, et al. Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review. Syst Rev 2018;7:4.
85. Cove ME, Pinsky MR. Perioperative hemodynamic monitoring. Best Pract Res Clin Anaesthesiol 2012;26:453–62.
86. Habler OP, Messmer KF. The physiology of oxygen transport. Transfus Sci 1997;18:425–35.
87. Zhou X, Zhang C, Wang Y, Yu L, Yan M. Preoperative Acute Normovolemic Hemodilution for minimizing allogenic blood transfusion: a meta-analysis. Anesth Analg 2015;121:1443–55.
88. Grant MC, Resar LM, Frank SM. The efficacy and utility of acute Normovolemic Hemodilution. Anesth Analg 2015;121:1412–4.
89. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010;CD001888.
90. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010;105:401–16.
91. Geoghegan J, Daniels JP, Moore PA, Thompson PJ, Khan KS, Gülmezoglu AM. Cell salvage at caesarean section: the need for an evidence-based approach. BJOG 2009;116:743–7.
92. National Institute for Health and Clinical Excellence. Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy. 2008 [Internet]; Available from http://guideance.nice.org.uk/IPG258 [cited 2019, Apr 24].
93. Liang TB, Li DL, Liang L, Li JJ, Bai XL, Yu W, et al. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 2008;85:863–9.
94. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbau-mer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005;45:103–10.
95. Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008;63:1332–8.
96. Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. Br J Anaesth 2008;101:225–9.
97. Feltracco P, Michieletto E, Barbieri S, Serra E, Rizzi S, Salvaterra F, et al. Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant Proc 2007;39:1889–91.
98. Allain JP, Akehurst RL, Hunter JM. Autologous transfusion, 3 yr on—what is new? What has happened? Second Consensus Conference on Autologous Transfusion. Br J Anaesth 1999;82:783–4.
99. Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014;96-B:1005–15.
100. Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 2014;29:2113–6.
101. Chen S, Wu K, Kong G, Feng W, Deng Z, Wang H. The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord 2016;17:81–8.
102. Hanna SA, Prasad A, Lee J, Achan P. Topical versus intravenous administration of tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Orthop Rev (Pavia) 2016;8:6792.
103. Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg 2012;78:1305–21.
104. Liu J, Cao JG, Wang L, Ma XL. Effect of fibrin sealant on blood loss following total knee arthroplasty: a systematic review and meta-analysis. Int J Surg 2014;12:95–102.
105. de Boer MT, Boonstra EA, Lisman T, Porte RJ. Role of fibrin sealants in liver surgery. Dig Surg 2012;29:54–61.
106. Orci LA, Oldani G, Berney T, Andres A, Mentha G, Morel P, et al. Systematic review and meta-analysis of fibrin sealants for patients undergoing pancreatic resection. HPB (Oxford) 2014;16:3–11.
107. Bracey A, Shander A, Aronson S, Boucher BA, Calcater-ra D, Chu MW, et al. The Use of Topical Hemostatic Agents in Cardiothoracic Surgery. Ann Thorac Surg 2017;104:353–60.
108. O’Connor PJ, Hanson J, Finucane BT. Induced hypotension with epidural/general anesthesia reduces transfusion in radical prostate surgery. Can J Anaesth 2006;53:873–80.
109. Freeman AK, Thorne CJ, Gaston CL, Shellard R, Neal T, Parry MC, et al. Hypotensive Epidural Anesthesia Reduces Blood Loss in Pelvic and Sacral Bone Tumor Resections. Clin Orthop Relat Res 2017;475:634–40.
110. Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 2008;37:687–703.
111. Forastiere E, Claroni C, Sofra M, Torregiani G, Covotta M, Marchione MG, et al. Evaluation of renal function under controlled hypotension in zero ischemia robotic assisted partial nephrectomy. Kidney Blood Press Res 2013;38:181–5.
112. Degoute CS. Controlled hypotension: a guide to drug choice. Drugs 2007;67:1053–76.
113. Lin S, McKenna SJ, Yao CF, Chen YR, Chen C. Effects of Hypotensive Anesthesia on Reducing Intraoperative Blood Loss, Duration of Operation, and Quality of Surgical Field During Orthognathic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Oral Maxillofac Surg 2017;75:73–86.
114. Dutton RP. Controlled hypotension for spinal surgery. Eur Spine J 2004;13(Suppl 1):S66–71.
115. Badiola IJ, Liu J, Neuman MD. Deliberate Hypotension for Hip Arthroplasty: Still More Questions Than Answers. Anesth Analg 2016;122:15–6.
116. Paul JE, Ling E, Lalonde C, Thabane L. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 2007;54:799–810.
117. Gillespie R, Shishani Y, Streit J, Wanner JP, McCrum C, Syed T, et al. The safety of controlled hypotension for shoulder arthroscopy in the beach-chair position. J Bone Joint Surg Am 2012;94:1284–90.
118. Kop EC, Spauwen PH, Kouwenberg PP, Heymans FJ, van Beem HB. Influence of controlled hypotension versus normotension on amount of blood loss during breast reduction. J Plast Reconstr Aesthet Surg 2009;62:200–5.
119. van Waes JA, van Klei WA, Wijeysundera DN, van Wolfswinkel L, Lindsay TF, Beattie WS. Association between Intraoperative Hypotension and Myocardial Injury after Vascular Surgery. Anesthesiology 2016;124:35–44.
120. Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013;119:507–15.
121. Brady K, Hogue CW. Intraoperative hypotension and patient outcome: does “one size fit all?”. Anesthesiology 2013;119:495–7.
122. Bombardieri AM, Sharrock NE, Ma Y, Go G, Drum-mond JC. An Observational Study of Cerebral Blood Flow Velocity During Hypotensive Epidural Anesthesia. Anesth Analg 2016;122:226–33.
123. Amer KM, Rehman S, Amer K, Haydel C. Efficacy and Safety of Tranexamic Acid in Orthopaedic Fracture Surgery: A Meta-Analysis and Systematic Literature Review. J Orthop Trauma 2017;31:520–5.
124. Fluids management and perioperative hemodynamic in high-risk patient [Internet]. Available from http://www.siaarti.it/SiteAssets/Ricerca/buone-pratiche-cliniche-SIAARTI-ges-tione-fluidi-ed-emodinamica-nel-paziente-ad-alto-rischio.pdf [cited 2019, Apr 24].
125. Standard monitoring in Anesthesia [Internet]. Available from http://www.siaarti.it/SiteAssets/Ricerca/Standard-per-ilmonitoraggio-in-Anestesia/linee_guida_file_43 [cited 2019, Apr 24].
126. Perioperative normothermia [Internet]. Available from http://www.siaarti.it/Ricerca/buone-pratiche-cliniche-siaartinormotermia-perioperatoria.aspx [cited 2019, Apr 24].
127. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054.
128. Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;CD001886.
129. Wallis JP, Wells AW, Whitehead S, Brewster N. Recovery from post-operative anaemia. Transfus Med 2005;15:413–8.
130. Bisbe E, Molto L, Arroyo R, Muniesa JM, Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014;113:402–9.
131. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006;53:11–9.
132. Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol 2016;3:e415–25.
133. Muñoz M, Slappendel R, Thomas D. Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion? Blood Transfus 2011;9:248–61.
134. Holst LB, Haase N, Wetterslev J, Wernerman J, Gut-tormsen AB, Karlsson S, et al.; TRISS Trial Group; Scandina-vian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371:1381–91.
135. Docherty AB, O’Donnell R, Brunskill S, Trivella M, Doree C, Holst L, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ 2016;352:i1351.
136. Bergamin FS, Almeida JP, Landoni G, Galas FR, Fu-kushima JT, Fominskiy E, et al. Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial. Crit Care Med 2017;45:766–73.
137. Fominskiy E, Putzu A, Monaco F, Scandroglio AM, Karaskov A, Galas FR, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. Br J Anaesth 2015;115:511–9.
138. Hare GM, Tsui AK, Ozawa S, Shander A. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol 2013;27:85–98.
139. Tim Goodnough L, Andrew Baker S, Shah N. How I use clinical decision support to improve red blood cell utilization. Transfusion 2016;56:2406–11.
140. Barr PJ, Donnelly M, Cardwell CR, Parker M, Morris K, Bailie KE. The appropriateness of red blood cell use and the extent of overtransfusion: right decision? Right amount? Transfusion 2011;51:1684–94.
141. Hess JR, Ramos PJ, Sen NE, Cruz-Cody VG, Tuott EE, Louzon MJ, et al. Quality management of a massive transfusion protocol. Transfusion 2018;58:480–4.
142. Savage SA, Sumislawski JJ, Zarzaur BL, Dutton WP, Croce MA, Fabian TC. The new metric to define large-volume hemorrhage: results of a prospective study of the critical administration threshold. J Trauma Acute Care Surg 2015;78:224–9.
143. Moren AM, Hamptom D, Diggs B, Kiraly L, Fox EE, Holcomb JB, et al.; PROMMTT Study Group. Recursive partitioning identifies greater than 4 U of packed red blood cells per hour as an improved massive transfusion definition. J Trauma Acute Care Surg 2015;79:920–4.
144. Foster JC, Sappenfield JW, Smith RS, Kiley SP. Initiation and Termination of Massive Transfusion Protocols: Current Strategies and Future Prospects. Anesth Analg 2017;125:2045–55.
145. Johansson PI, Stensballe J, Oliveri R, Wade CE, Os-trowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood 2014;124:3052–8.
146. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, et al.; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013;148:127–36.
147. McQuilten ZK, Crighton G, Brunskill S, Morison JK, Richter TH, Waters N, et al. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review. Transfus Med Rev 2018;32:6–15.
148. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al.; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23–32.
149. Oliver JC, Griffin RL, Hannon T, Marques MB. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion 2014;54:2617–24.
150. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012;116:1367–76.